Revvity (NYSE:RVTY) Releases FY 2025 Earnings Guidance

Revvity (NYSE:RVTY) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 5.000- for the period, compared to the consensus earnings per share estimate of 4.910. The company issued revenue guidance of $2.9 billion-$2.9 billion, compared to the consensus revenue estimate of $2.8 billion. Revvity also updated its Q4 2025 guidance to EPS.

Wall Street Analyst Weigh In

A number of brokerages have commented on RVTY. Robert W. Baird lifted their target price on Revvity from $122.00 to $123.00 and gave the company an “outperform” rating in a research note on Tuesday, October 28th. Wells Fargo & Company boosted their price objective on Revvity from $102.00 to $107.00 and gave the company an “equal weight” rating in a research report on Monday, December 15th. The Goldman Sachs Group began coverage on Revvity in a research note on Tuesday, December 9th. They set a “neutral” rating and a $105.00 price objective for the company. Guggenheim began coverage on Revvity in a research note on Wednesday, October 15th. They issued a “neutral” rating on the stock. Finally, Evercore ISI restated an “outperform” rating on shares of Revvity in a research report on Monday, January 5th. Six analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $113.91.

Revvity Trading Down 0.5%

Shares of RVTY stock opened at $103.96 on Tuesday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.44 and a current ratio of 1.75. Revvity has a 1 year low of $81.36 and a 1 year high of $128.29. The stock has a fifty day moving average of $98.31 and a two-hundred day moving average of $94.09. The firm has a market capitalization of $11.79 billion, a PE ratio of 52.24, a price-to-earnings-growth ratio of 3.19 and a beta of 1.05.

Revvity (NYSE:RVTY) last issued its quarterly earnings results on Monday, October 27th. The company reported $1.18 EPS for the quarter, beating analysts’ consensus estimates of $1.14 by $0.04. Revvity had a return on equity of 7.52% and a net margin of 8.44%.The company had revenue of $698.95 million for the quarter, compared to analyst estimates of $699.75 million. During the same period last year, the company earned $1.28 earnings per share. The company’s quarterly revenue was up 2.2% compared to the same quarter last year. Revvity has set its FY 2025 guidance at 4.900-5.000 EPS. As a group, research analysts expect that Revvity will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 6th. Shareholders of record on Friday, January 16th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, January 16th. This represents a $0.28 annualized dividend and a yield of 0.3%. Revvity’s dividend payout ratio (DPR) is presently 14.07%.

Revvity announced that its board has approved a share repurchase program on Monday, October 27th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the company to repurchase up to 8.7% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s management believes its shares are undervalued.

Institutional Investors Weigh In On Revvity

Several hedge funds and other institutional investors have recently added to or reduced their stakes in RVTY. CYBER HORNET ETFs LLC acquired a new stake in Revvity in the second quarter worth approximately $32,000. MUFG Securities EMEA plc acquired a new position in shares of Revvity during the 2nd quarter valued at $34,000. Headlands Technologies LLC bought a new stake in shares of Revvity in the 2nd quarter worth $49,000. EverSource Wealth Advisors LLC lifted its holdings in shares of Revvity by 25.9% in the second quarter. EverSource Wealth Advisors LLC now owns 900 shares of the company’s stock valued at $87,000 after buying an additional 185 shares during the period. Finally, Nomura Holdings Inc. bought a new position in Revvity during the third quarter valued at about $270,000. Institutional investors own 86.65% of the company’s stock.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.